ABL offers new CE marked test for SARS-CoV-2 mutation detection
Advanced Biological Laboratories (ABL), a Luxembourg-based medical data technology company, announced today the CE-IVD registration of its UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations. Targeting key mutations on the virus, the test helps in this identification of the main variants of concern including lineages Delta and soon Lambda, synonymous with higher transmissibility and […]
